Similar safety results of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) from a phase III trial in patients (pts) with previously untreated advanced gastric cancer (AGC)

被引：0
|
作者：
Kang, Y. K.
Kang, W. K.
Shin, D. B.
Chen, J.
Xiong, J.
Wang, J.
Lichinitser, M.
Salas, M. P.
Suarez, T.
Santamaria, J.
机构：
[1] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Samsung Med Ctr, Dept Internal Med, Ilwon Dong, South Korea
[3] Gachon Med Sch, Gil Med Ctr, Dept Internal Med, Guwal Dong, South Korea
[4] Jiangsu Canc Hosp, Jiangsu, Peoples R China
[5] 1st Affiliated Hosp, Jianxi Med Coll, Jianxi, Peoples R China
[6] Shanghai Changzheng Hosp, Shanghai, Peoples R China
[7] Russian Canc Res Ctr, Blokhin Canc Res Ctr, Moscow, Russia
[8] Hosp Sabogal, Lima, Peru
[9] Ctr Med Pensiones, Yucatan, Mexico
[10] Inst Oncol Nacl, Ancon, Panama
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [21] QUALITY OF LIFE IN FLAGS TRIAL A RANDOMIZED, COMPARATIVE, OPEN LABEL, MULTICENTER, PHASE 3 OF S-1+CISPLATIN (CS) COMPARED TO 5-FU + CISPLATIN (CF) IN UNTREATED ADVANCED GASTRIC CANCER (AGC) PATIENTS
    Bodoky, G.
    Carrato, A.
    Ravaioli, A.
    Ajani, J. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 232 - 233
  • [22] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WOOLLEY, P
    SMITH, F
    ESTEVEZ, R
    GISSELBRECHT, C
    ALVAREZ, C
    BOIRON, M
    MACHADO, C
    LAGARDE, C
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 455 - 455
  • [23] Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin
    Boku, Narikazu
    Ohtsu, Atsushi
    Yoshida, Shigeaki
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Hyodo, Ichinosuke
    Saito, Hiroshi
    Miyata, Yoshinori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (04) : 275 - 281
  • [24] Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma:: A randomised phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Vielhaber, A
    Dörken, B
    Reichardt, P
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [25] Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients (pts) with untreated advanced gastric cancer (AGC)
    Nakajima, T. E.
    Satoh, T.
    Muro, K.
    Yamada, Y.
    Shimada, Y.
    Takahari, D.
    Hayashi, H.
    Taku, K.
    Shi, X.
    Boku, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [26] Initial safety findings from XELOXA: a randomised phase III trial of capecitabine plus oxaliplatin vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer
    Schmoll, H.
    Tabernero, J.
    Nowacki, M.
    Maroun, J.
    Price, T.
    Lim, R.
    Van Cutsem, E.
    de Braud, F.
    Haller, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 174 - 174
  • [27] Early safety findings from a phase III trial of capecitabine plus oxaliplatin (XELOX) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer.
    Schmoll, HJ
    Tabernero, J
    Nowacki, M
    Maroun, J
    Figer, A
    Price, T
    Lim, R
    van Cutsem, E
    Haller, D
    Braud, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 251S - 251S
  • [28] Capecitabine plus oxaliplatin (XELOX) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer: Final safety findings from a randomized phase III trial
    Schmoll, H.
    Tabernero, J.
    Nowacki, M.
    Maroun, J.
    Price, T.
    Lim, R.
    Van Cutsem, E.
    de Braud, F.
    Haller, D.
    ANNALS OF ONCOLOGY, 2006, 17 : 25 - 26
  • [29] Phase II study of paclitaxel, cisplatin, and 5-FU combination chemotherapy in patients with advanced gastric cancer
    Cho, S.
    Shim, H.
    Lee, S.
    Ahn, J.
    Yang, D.
    Kim, Y.
    Park, C.
    Lee, J.
    Chung, I.
    Kim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
    Lordick, Florian
    Kang, Yoon-Koo
    Chung, Hyun-Cheol
    Salman, Pamela
    Oh, Sang Cheul
    Bodoky, Gyoergy
    Kurteva, Galina
    Volovat, Constantin
    Moiseyenko, Vladimir M.
    Gorbunova, Vera
    Park, Joon Oh
    Sawaki, Akira
    Celik, Ilhan
    Goette, Heiko
    Melezinkova, Helena
    Moehler, Markus
    LANCET ONCOLOGY, 2013, 14 (06): : 490 - 499
12345